Qiagen (QGEN) Research & Development (2009 - 2025)

Qiagen has disclosed Research & Development across 17 years of filings, most recently posting $47.2 million for Q4 2025.

• Research & Development for Q4 2025 came in at $47.2 million, down 2.82% year-over-year; the trailing twelve-month figure through Dec 2025 was $187.5 million (down 3.09% YoY), and the FY2025 annual result was $187.5 million, down 3.09% from the prior year.
• Research & Development came in at $47.2 million for Q4 2025 at Qiagen, down from $48.7 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $54.7 million in Q1 2023 to a low of $42.1 million in Q4 2021.
• The 5-year median for Research & Development is $47.9 million (2023), against an average of $48.0 million.
• Across the five-year window, Research & Development jumped 36.25% in 2021 and declined 14.71% in 2025, its largest moves.
• Qiagen's Research & Development stood at $42.1 million in 2021, then rose by 6.19% to $44.7 million in 2022, then gained by 2.79% to $46.0 million in 2023, then grew by 5.74% to $48.6 million in 2024, then slipped by 2.82% to $47.2 million in 2025.
• The last three Research & Development figures came in at $47.2 million (Q4 2025), $48.7 million (Q3 2025), and $47.8 million (Q2 2025), per Business Quant data.